FUJIFILM Diosynth Biotechnologies appointed Maja Pedersen Chief Quality Officer (CQO). She will report to President and CEO Lars Petersen and will serve as a member of the executive leadership team, leading the company’s global quality team.

Pedersen brings 20 years of leadership experience in the life sciences and biopharma space serving senior leadership positions in quality assurance and control, regulatory affairs, and external manufacturing. Pedersen returns to the company from Biogen where she most recently served as the global head of external manufacturing overseeing the entire CDMO network. Prior to that, she served as the head of quality and qualified person, where she was responsible for the successful startup of large-scale manufacturing capabilities and securing commercial manufacturing licenses for products with both FUJIFILM Diosynth Biotechnologies and Biogen. 

“We are pleased to welcome back Maja Pedersen to FUJIFILM Diosynth Biotechnologies to lead our global quality initiatives,” said Lars Petersen, President, and CEO, FUJFILM Diosynth Biotechnologies. “She has tremendous experience driving a quality culture with focus on patients and with a firm belief in quality as an enabler which has proven to deliver results in strong quality ownership across functions.”

“I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture,” said Pedersen. “Reliability and quality are cornerstones in the company’s strategic principles, and I am excited to be engaging with our people and our partners on how we ensure unprecedented customer delivery for the benefit of patients.”